As Thursday’s Supreme Court ruling on the health care law is examined, experts are citing concerns about the Medicaid decision, which could end up insuring fewer Americans as states opt out of expansion.
May 04, 2012
Academic medical centers can play a larger role in drug development and testing, according to an FDA official, who says there is a need for better strategies to identify winners, minimize costs and reduce failures during drug development.
March 07, 2012
UCSF has launched a new web portal that offers researchers, study coordinators and study participants an easy-on-the-eyes, logically arranged and comprehensive tool that will guide them to a wealth of much-needed information about clinical trials.
February 02, 2012
An analysis of hundreds of reviews posted to physician-rating sites on the Internet revealed that patients generally give their doctors favorable reviews in this forum. If they complain, it is generally about the experience of going to the doctor.
January 26, 2012
John Corrin Hutchinson, MD, or “Hutch” to many, professor emeritus and Distinguished Fellow of the American College of Cardiology, passed away peacefully on Jan. 14, 2012. He was 84.
December 22, 2011
In a commentary published in the November issue of Academic Medicine, top recruitment experts at UCSF urge academic medical researchers to embrace new methods for recruiting participants into clinical trials.
December 02, 2011
As physicians working on the frontlines of HIV/AIDS since its start 30 years ago near retirement, UCSF is looking to attract and train the next generation of doctors to specialize in HIV/AIDS medicine.
September 29, 2011
It’s a matter of fairness: members of all ethnic groups should have the opportunity to participate in clinical trials. And it’s a matter of soundness, too: medical advancements must be tested in as many different people with as many different genetic makeups as possible.
August 12, 2011
UC scientists explain radiation risks from everyday background radiation, medical imaging and nuclear power plant accidents in the aftermath of meltdowns at the Fukushima Daiichi nuclear power plant in Japan.
May 05, 2011
Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.